U.S. Healthtech Stock News

Mach Natural Resources (MNR) has put income front and center, with its board declaring a fourth quarter 2025 cash distribution of $0.53 per common unit to unitholders of record on February 26, 2026. See our latest analysis for Mach Natural Resources. The latest distribution news lands after a stretch of firm share price momentum, with a 30 day share price return of 19.2% and a 90 day share price return of 10.74%. This comes even though the 1 year total shareholder return is a 6.69% decline,...

Progressive (PGR) is back in focus after several major banks reaffirmed positive views following strong December and quarterly results, as rising net premiums and solid profitability metrics draw fresh attention from insurance sector investors. See our latest analysis for Progressive. At a share price of $204.53, Progressive’s 1-day share price return of a 0.45% decline and 90-day share price return of a 9.24% decline compare with a 5-year total shareholder return of 162.88%. This indicates...

D-Wave Quantum has recently secured larger commercial agreements, including a US$10 million, two-year quantum computing-as-a-service deal with a Fortune 100 company and a US$20 million Advantage2 system installation at Florida Atlantic University, while also acquiring Quantum Circuits for US$550 million to accelerate its gate-model roadmap. These moves signal D-Wave’s push to pair its established annealing technology with a developing universal gate-model platform, aiming to serve both...

Regency Centers Corporation recently reported fourth-quarter 2025 results, with sales of US$393.48 million, revenue of US$404.19 million, and net income of US$202.48 million, while also declaring common and preferred dividends and confirming full-year 2026 earnings guidance. Alongside these earnings, the company announced that long-serving director C. Ronald Blankenship will retire after the 2026 Annual Meeting, marking a planned board transition as Regency outlines its financial...

Carlyle Group (CG) is back in focus after reporting fourth quarter results that topped Wall Street expectations on both revenue and non GAAP earnings per share, prompting a broadly positive reaction from analysts. See our latest analysis for Carlyle Group. Carlyle’s recent earnings beat, dividend affirmation and ongoing share buybacks come against a share price that has pulled back, with a 30 day share price return of 16.96% and a year to date share price decline of 10.47%, even as the 1 year...

Kaskela Law LLC recently launched an investigation into Ingram Micro Holding Corporation, examining whether the company and its leadership may have violated securities laws or breached fiduciary duties in connection with recent corporate actions. This legal review introduces an additional layer of governance and compliance scrutiny that could influence how shareholders assess management decisions and corporate transparency. Next, we’ll explore how this shareholder investigation may affect...

In recent days, GATX’s business update highlighted slower-than-hoped adoption of its railcar solutions, rising cash burn, and a tight liquidity position that could require fresh equity financing. At the same time, the company has attracted strong institutional interest and AI-driven trading support, with market participants emphasizing operational momentum and long-term leasing fundamentals despite these financial pressures. We’ll now examine how this mix of robust institutional support and...

Sterling Infrastructure (STRL) is back in focus after quarterly earnings topped analyst expectations and the company approved a new $400 million share repurchase program, prompting investors to reassess the stock’s recent outperformance. See our latest analysis for Sterling Infrastructure. The recent 1-month share price return of 24.73% and 90-day share price return of 31.53% have pushed Sterling Infrastructure to a US$437.77 share price, building on very large 1-year and multi year total...

Why Bio-Techne Is Back on Investor Radar Bio-Techne (TECH) has drawn fresh attention after quarterly results topped Wall Street expectations, supported by large pharmaceutical customers, tighter cost control and new product momentum in 3D stem cell and organoid research tools. See our latest analysis for Bio-Techne. Those earnings and product updates have landed against a mixed share price backdrop, with a 12.73% 1 month share price decline and an 8.58% 1 year total shareholder return...

Earlier this month, Valley National Bancorp appointed Rodrigo Suarez, Stephen Schroth, and Ed Montesdeoca to senior roles overseeing partner banking, digital channels, and customer care, signaling a push into fintech partnerships and enhanced digital service capabilities. This leadership shift places digital transformation and embedded banking at the center of Valley’s operating model, potentially reshaping how it pursues growth and customer engagement. We’ll now examine how Valley’s new...

WEX (WEX) has just wrapped up FY 2025 with Q4 revenue of US$672.9 million and basic EPS of US$2.45, while full year trailing twelve month revenue came in at about US$2.7 billion and EPS at US$8.57. Over recent quarters the company has seen revenue move from US$636.5 million in Q4 2024 to US$672.9 million in Q4 2025, with basic EPS shifting from US$1.62 to US$2.45 over the same period, giving investors a clear view of how the top and bottom lines have tracked into this latest print. With a...

If you are wondering whether Hanover Insurance Group's share price still reflects its underlying worth, this article walks through the key numbers that matter before you commit fresh capital. The stock closed at US$171.80, with returns of 1.1% over 30 days, 7.8% over 1 year, 29.3% over 3 years and 70.4% over 5 years. This recent price history gives useful context for judging current value and risk. Recent coverage has focused on Hanover Insurance Group's position in the US insurance sector...

Trimble (TRMB) is back in focus after reporting 2025 results that topped revenue and earnings expectations, alongside guidance for 2026 that points to further growth in recurring revenue and operating margins. See our latest analysis for Trimble. Despite the upbeat 2025 results and 2026 outlook, Trimble’s recent share price performance has been softer. The 30 day share price return is 10.14% and the year to date share price return is 15.23%, while the 3 year total shareholder return of 20.29%...

Solstice Advanced Materials (SOLS) is in focus after its fourth quarter 2025 earnings, its first quarterly dividend declaration, and a planned 20% output increase at its Metropolis Works nuclear conversion facility. See our latest analysis for Solstice Advanced Materials. The recent Q4 update, dividend initiation and the planned UF6 capacity increase have coincided with a sharp acceleration in momentum, with Solstice’s 90 day share price return of 88.12% and year to date share price return of...

For investors wondering whether Encompass Health at around US$110 a share still offers value, or if the easy money has already been made, this article explains what the current price reflects. The stock has returned 4.5% over the last 7 days, 9.6% over 30 days, 3.5% year to date, 9.9% over 1 year, 79.3% over 3 years and 81.5% over 5 years. These figures naturally raise questions about what is now priced in. Recent attention on Encompass Health has focused on its position within US healthcare...

What the latest earnings mean for Baxter International (BAX) Baxter International (BAX) is back in focus after its fourth quarter 2025 update combined higher sales with weaker profitability, cautious 2026 guidance, and a sharp market reaction to the softer earnings outlook. See our latest analysis for Baxter International. The earnings-driven sell off has come on top of a longer slump, with the share price at US$19.79 after a 1 day share price return of 5.77% but a 1 year total shareholder...

Pulmovant, a Roivant Sciences company, has completed patient enrollment in the Phase 2 PHocus trial of mosliciguat for pulmonary hypertension associated with interstitial lung disease. Enrollment finished ahead of schedule, marking a key clinical milestone for this potential first in class inhaled therapy. For investors watching Roivant Sciences (NasdaqGS:ROIV), this clinical update adds fresh context to a stock that has seen a very large 1 year return and a 20.6% gain year to date. Shares...

In early February 2026, Fortive Corporation reported fourth-quarter 2025 sales of US$1,122.5 million with continuing operations EPS edging higher year on year, even as full-year net income fell to US$579.2 million on modestly higher sales of US$4,159.1 million. Alongside these results, Fortive completed a multi-year buyback program totaling 43,483,303 shares for US$2,734.24 million, while management highlighted expanding recurring revenue and strong demand in its Fluke and international...

What Nabors Industries’ Recent Returns Signal for Investors Nabors Industries (NBR) has drawn fresh attention after a recent move in its share price, with a 6.6% gain over the past day and double digit returns over the past month and past 3 months. At a last close of US$68.10, the stock reflects a year to date return of 22.9% and a 1 year total return of 44.3%. Over longer periods, the 3 year total return stands at a 56.2% decline and the 5 year total return shows a 22.1% decline. Alongside...

Why Sysco’s new $1.25b in senior notes matters for stock watchers Sysco (SYY) has just issued $1.25b of new senior notes, mainly to refinance commercial paper and support general corporate uses. This gives stock investors fresh information about its capital structure and debt profile. See our latest analysis for Sysco. The new senior notes come as Sysco’s share price has gained 14.9% over the past month and 20.5% over the last 90 days, with a 1 year total shareholder return of 30.9%. This...

Investors may be wondering whether Enpro is still fairly priced after a strong run, or if the current level is starting to look stretched for new money going in. The stock last closed at US$272.63, with returns of 1.9% over 7 days, 12.0% over 30 days, 24.4% year to date, 42.2% over 1 year, 133.4% over 3 years and 265.3% over 5 years. This naturally raises questions about what is already reflected in the price. Recent coverage of Enpro has focused on its position in the capital goods space...

LGI Homes (LGIH) has put its Terrata Homes luxury brand on the map in California with the grand opening of Murieta Hills, a premium, guard gated community near Sacramento. See our latest analysis for LGI Homes. The Murieta Hills launch and January update on 218 home closings arrive as LGI Homes’ share price has gained 13.07% over the past month and 45.84% year to date, yet its 1 year total shareholder return of 28.53% decline and 5 year total shareholder return of 48.88% decline suggest...

Extreme Networks (EXTR) is in focus after announcing E-Rate eligible networking solutions for K-12 schools and libraries, centered on its new AI powered Extreme Platform ONE and supporting Wi-Fi, switching, and fabric products. See our latest analysis for Extreme Networks. At a share price of US$14.46, Extreme Networks has seen a 2.26% 1 day share price return. The 30 day and year to date share price returns of 9.40% and 12.58% suggest momentum has been fading despite the new K 12 focused AI...

If you are wondering whether e.l.f. Beauty's share price still lines up with its underlying worth, this article will walk through what the current numbers are actually telling you. The stock most recently closed at US$81.50, with a 0.7% decline over 7 days, a 9.4% decline over 30 days, a 4.7% gain year to date, an 11.6% gain over 1 year and a very large gain over 5 years. Recent news flow around e.l.f. Beauty has focused on its position as a mass market cosmetics brand that aims to compete...